US Stock MarketDetailed Quotes
ACUR Acura Pharmaceuticals Inc
- 0.020000
- 0.0000000.00%
15min DelayTrading Jul 25 16:00 ET
1.32MMarket Cap-1000P/E (TTM)
0.000000High0.000000Low35Volume0.003000Open0.020000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)66.00MShares0.05000052wk High6.67P/B163.77KFloat Cap0.00000152wk Low--Dividend TTM8.19MShs Float1725.000000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
Acura Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3.20%-742K | -432.50%-426K | 135.05%191K | 56.01%-194K | -190.20%-313K | -16.34%-719K | -115.33%-80K | -190.83%-545K | 67.11%-441K | 186.97%347K |
| Net income from continuing operations | 27.24%-879K | 111.93%29K | 61.36%-262K | -225.65%-387K | 56.47%-259K | 67.99%-1.21M | -256.77%-243K | -439.00%-678K | 109.22%308K | 24.49%-595K |
| Operating gains losses | ---535K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -28.00%90K | 42.11%27K | 35.00%27K | -10.00%18K | -72.73%18K | -54.21%125K | -71.64%19K | -71.01%20K | -71.01%20K | -2.94%66K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | -520.75%-223K | --0 | --0 | ---- | ---- |
| Change In working capital | 507.69%477K | -105.93%-8K | 295.19%411K | 126.31%146K | -136.18%-72K | -196.69%-117K | -51.61%135K | -65.45%104K | 23.76%-555K | -26.02%199K |
| -Change in receivables | 217.54%469K | 29.05%382K | 855.26%574K | 75.81%-180K | -345.60%-307K | -1,006.82%-399K | 1,309.52%296K | -111.60%-76K | -4.35%-744K | 54.32%125K |
| -Change in prepaid assets | 41.18%-10K | -2.90%67K | -22.88%-188K | 180.00%56K | 17.02%55K | -138.64%-17K | 9.52%69K | -11.68%-153K | -60.00%20K | -30.88%47K |
| -Change in payables and accrued expense | -111.76%-34K | -105.60%-477K | -91.57%28K | 46.88%235K | 520.69%180K | 1,826.67%289K | -218.97%-232K | 240.08%332K | 375.86%160K | -74.78%29K |
| -Change in other current liabilities | 420.00%52K | 900.00%20K | -400.00%-3K | 288.89%35K | --0 | -44.44%10K | --2K | -95.00%1K | 228.57%9K | -140.00%-2K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.20%-742K | -432.50%-426K | 135.05%191K | 56.01%-194K | -190.20%-313K | -16.34%-719K | -115.33%-80K | -190.83%-545K | 67.11%-441K | 186.97%347K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 45.93%394K | 402K | -269K | 0 | 26,000.00%261K | -80.56%270K | 0 | 0 | -78.67%269K | -99.75%1K |
| Net issuance payments of debt | 48.33%399K | --133K | --0 | --0 | --266K | -80.44%269K | --0 | --0 | -78.48%269K | --0 |
| Net common stock issuance | 0.00%3K | --0 | --0 | --0 | 0.00%3K | -78.57%3K | --0 | --0 | --0 | 0.00%3K |
| Net other financing activities | -300.00%-8K | --269K | ---269K | --0 | -300.00%-8K | ---2K | --0 | --0 | --0 | ---2K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 45.93%394K | --402K | ---269K | --0 | 26,000.00%261K | -80.56%270K | --0 | --0 | -78.67%269K | -99.75%1K |
| Net cash flow | ||||||||||
| Beginning cash position | -52.09%413K | -81.95%89K | -83.91%167K | -70.17%361K | -52.09%413K | 847.25%862K | -19.84%493K | 6,820.00%1.04M | 1,173.68%1.21M | 847.25%862K |
| Current changes in cash | 22.49%-348K | 70.00%-24K | 85.69%-78K | -12.79%-194K | -114.94%-52K | -158.24%-449K | -132.39%-80K | -190.83%-545K | -115.00%-172K | 8,600.00%348K |
| End cash Position | -84.26%65K | -84.26%65K | -81.95%89K | -83.91%167K | -70.17%361K | -52.09%413K | -52.09%413K | -19.84%493K | 6,820.00%1.04M | 1,173.68%1.21M |
| Free cash flow | -3.20%-742K | -432.50%-426K | 135.05%191K | 56.01%-194K | -190.20%-313K | -16.34%-719K | -115.33%-80K | -190.83%-545K | 67.11%-441K | 186.97%347K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg